Sveriges mest populära poddar
PharmaSource Podcast
VetenskapLife Science

CDMO Live Europe 2026: Building Europe's Premier BioPharma Outsourcing Platform

8 min•15 september 2025

In this episode Luke Bilton, Co-Founder of PharmaSource, shares a special announcement about CDMO Live Europe 2026 (May 19-21, Rotterdam World Trade Center).

Following a sold-out inaugural event that facilitated over 1,200 targeted meetings, this pharmaceutical outsourcing event is doubling in size in 2026.

Key topics covered:

  • Why the £200+ billion CDMO sector needed a dedicated European platform
  • New learning tracks for External Manufacturing Strategy and Drug Development & CMC
  • Hands-on training sessions including Strategic Partnership development and Biotech CMC Bootcamp
  • Expanded PartnerMatch concierge system connecting pharma companies with more than 80 CDMOs


Learn more about CDMO Live Europe here


Fler avsnitt av PharmaSource Podcast

Visa alla avsnitt av PharmaSource Podcast
How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform
•23 min
Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models
•30 min
Hybrid Synthesis is Redefining Peptide Manufacturing
•29 min
The Case for Strategic CDMO Partnerships Over Multi-Sourcing
•32 min
CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO
•47 min
Trump's Most-Favored-Nation Policy Is Forcing Europe's Pharma Industry to Reconsider Its Pricing Strategy
•27 min
How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains
•22 min
Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy
•36 min
How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO
•31 min
U.S. Vaccine Policy Shifts are Create a “Chilling” Effect on Global Manufacturing and Innovation
•35 min

PharmaSource Podcast med Life Science Networks finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.